Why We Think Cubist Pharmaceuticals Has Incredible Upside
- Cubist is a pharmaceutical company with great past performance, and we think the company is poised to deliver great returns in the future.
- We think Dificid, a drug used to treat Clostridium difficile infections, is under-appreciated.
- The company’s drug pipeline is poised to help solve very important problems in medicine.
- The company recently reported fantastic earnings and we think more great quarters are to come.